Prolactinomas: diagnosis and treatment

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2012 English Publisher:Informa UK LimitedJournal:Expert Review of Endocrinology & Metabolism, volume 7, pages 233-241 (issn: 1744-6651, eissn: 1744-8417,

Copyright policy )

Authors: Farshad, Nassiri; Michael D, Cusimano; Bernd W, Scheithauer; Fabio, Rotondo; Alessandra, Fazio; Luis V, Syro; Kalman, Kovacs; +1 Authors

doi: 10.1586/eem.12.4

pmid: 30764014

Prolactinomas: diagnosis and treatment

- Summary
- Metrics

Abstract

Pituitary lactotrophs secrete prolactin. This process is enhanced by estrogen and inhibited by dopamine. Prolactinomas are benign neoplasms that rarely increase in size and are classified according to size as microadenomas (10 mm diameter). The clinical features of prolactinomas most commonly result from prolactin's effect on the gonads and breast in women and from mass effect in men. This review details the clinical features and management of patients with prolactinomas.

Related Organizations

University of Toronto
Canada
University of Wisconsin Hospital and Clinics
United States
Mayo Clinic
United States
St. Michael's Hospital
Canada
Hospital Pablo Tobon Uribe
Colombia

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	4
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average